COVID-19 after the first wave of the pandemic among employees from a German university hospital: prevalence and questionnaire data.
SARS-CoV-2
antibody
health care workers
Journal
Journal of medicine and life
ISSN: 1844-3117
Titre abrégé: J Med Life
Pays: Romania
ID NLM: 101477617
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
27
04
2022
accepted:
04
07
2022
entrez:
23
11
2022
pubmed:
24
11
2022
medline:
25
11
2022
Statut:
ppublish
Résumé
The SARS-CoV-2 pandemic has changed lives around the world. In particular, healthcare workers faced significant challenges as a result of the pandemic. This study investigates the seroprevalence of SARS-CoV-2 in March-April 2020 in Germany among healthcare workers and relates it to questionnaire data. In June 2020, all employees of the reporting hospital were offered a free SARS-CoV-2 antibody test. The first 2,550 test results were sent along with study documents. The response rate was 15.1%. The COVID-19 PCR test prevalence amongst health care workers in this study was 1.04% (95% CI 0.41-2.65%), higher by a factor of 5 than in the general population (p=0.01). The ratio of seroprevalence to PCR prevalence was 1.5. COVID-19-associated symptoms were also prevalent in the non-COVID-19-positive population. Only two symptoms showed statistically significant odds ratios, loss of smell and loss of taste. Health care workers largely supported non-pharmaceutical interventions during the initial lockdown (93%). Individual behavior correlated significantly with attitudes toward policy interventions and perceived individual risk factors. Our data suggest that healthcare workers may be at higher risk of infection. Therefore, a discussion about prioritizing vaccination makes sense. They also support offering increased SARS-CoV-2 testing to hospital workers. It is concluded that easier access to SARS-CoV-2 testing reduces the number of unreported cases. Furthermore, individual attitudes toward rules and regulations on COVID-19 critically influence compliance. Thus, one goal of public policy should be to maintain high levels of support for non-pharmaceutical interventions to keep actual compliance high.
Identifiants
pubmed: 36415516
doi: 10.25122/jml-2022-0126
pii: JMedLife-15-1119
pmc: PMC9635233
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1119-1128Informations de copyright
©2022 JOURNAL of MEDICINE and LIFE.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Lancet Infect Dis. 2020 Dec;20(12):1401-1408
pubmed: 32758438
Eur J Trauma Emerg Surg. 2022 Apr;48(2):841-846
pubmed: 33856507
Thorax. 2020 Dec;75(12):1089-1094
pubmed: 32917840
Brain Behav. 2020 Nov;10(11):e01839
pubmed: 32935915
BMC Public Health. 2021 Feb 13;21(1):352
pubmed: 33581734
Postgrad Med. 2020 Nov;132(8):749-755
pubmed: 32573311
Nat Commun. 2020 Nov 17;11(1):5829
pubmed: 33203887
J Hosp Infect. 2021 Feb;108:120-134
pubmed: 33212126
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
J Microbiol Immunol Infect. 2021 Feb;54(1):12-16
pubmed: 32425996
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Euro Surveill. 2020 Jun;25(23):
pubmed: 32553062
Nat Microbiol. 2020 Dec;5(12):1598-1607
pubmed: 33106674
J Hosp Infect. 2020 Jun;105(2):183-187
pubmed: 32278701
mBio. 2021 Feb 9;12(1):
pubmed: 33563817
Am J Infect Control. 2021 Feb;49(2):238-246
pubmed: 32659414